Skip to main content
SpringerLink
Log in

Primary hypertrophic osteoarthropathy: an update

  • Review
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

Digital clubbing, which has been recognized as a sign of systemic disease, is one of the most ancient diseases. However, the pathogenesis of clubbing and hypertrophic osteoarthropathy has hitherto been poorly understood. The study of a clinically indistinguishable idiopathic form (primary hypertrophic osteoarthropathy, PHO) provides an opportunity to understand the pathogenesis of hypertrophic osteoarthropathy. Current advances in the study of PHO are discussed. The impaired metabolism of prostaglandin E2 (PGE2) plays a central role in its pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Castori M, Sinibaldi L, Mingarelli R, Lachman RS, Rimoin DL, Dallapiccola B. Pachydermoperiostosis: an update. Clin Genet 2005; 68(6): 477–486

    Article  PubMed  CAS  Google Scholar 

  2. Friedreich N. Hyperostose des gesammten skelettes. Virchows Arch 1868; 43(1): 83–87

    Article  Google Scholar 

  3. Touraine A, Solente G, Gole L. Un syndrome osteodermopathique: la pachydermie plicaturee avec pachyperiostose des extremites. Presse Med 1935; 43: 1820–1824

    Google Scholar 

  4. Jajic I. Epidemiology of hypertrophic osteoarthropathy. Clin Exp Rheumatol 1992; 10(Suppl 7): 13

    PubMed  Google Scholar 

  5. Oikarinen A, Palatsi R, Kylmäniemi M, Keski-Oja J, Risteli J, Kallioinen M. Pachydermoperiostosis: analysis of the connective tissue abnormality in one family. J Am Acad Dermatol 1994; 31(6): 947–953

    Article  PubMed  CAS  Google Scholar 

  6. Harbison JB, Nice CM Jr. Familial pachydermoperiostosis presenting as an acromegaly-like syndrome. Am J Roentgenol Radium Ther Nucl Med 1971; 112(3): 532–536

    Article  PubMed  CAS  Google Scholar 

  7. Rimoin DL. Pachydermoperiostosis (Idiopathic Clubbing and Periostosis): genetic and physiologic considerations. N Engl J Med 1965; 272(18): 923–931

    Article  PubMed  CAS  Google Scholar 

  8. Currarino G, Tierney RC, Giesel RG, Weihl C. Familial idiopathic osteoarthropathy. Am J Roentgenol Radium Ther Nucl Med 1961; 85: 633–644

    PubMed  CAS  Google Scholar 

  9. Chamberlain DS, Whitaker J, Silverman FN. Idiopathic Osteoarthropathy and Cranial Defects in Children (Familial Idiopathic Osteoarthropathy). Am J Roentgenol Radium Ther Nucl Med 1965; 93: 408–415

    PubMed  CAS  Google Scholar 

  10. Guyot-Drouot MH, Solau-Gervais E, Cortet B, Deprez X, Chastanet P, Cotten A, Delcambre B, Flipo RM. Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. J Rheumatol 2000; 27(10): 2418–2423

    PubMed  CAS  Google Scholar 

  11. Martinez-Lavin M. Miscellaneous non-inflammatory musculoskeletal conditions. Pachydermoperiostosis. Best Pract Res Clin Rheumatol 2011; 25(5): 727–734

    Article  PubMed  CAS  Google Scholar 

  12. Sinha GP, Curtis P, Haigh D, Lealman GT, Dodds W, Bennett CP. Pachydermoperiostosis in childhood. Br J Rheumatol 1997; 36(11): 1224–1227

    Article  PubMed  CAS  Google Scholar 

  13. Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, Ibrahim GH, Helliwell PS, Latos-Bieleńska A, Phillips SE, Markham AF, Bennett CP, Bonthron DT. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 2008; 40(6): 789–793

    Article  PubMed  CAS  Google Scholar 

  14. Zhang Z, Xia W, He J, Zhang Z, Ke Y, Yue H, Wang C, Zhang H, Gu J, Hu W, Fu W, Hu Y, Li M, Liu Y. Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am J Hum Genet 2012; 90(1): 125–132

    Article  PubMed  CAS  Google Scholar 

  15. Diggle CP, Parry DA, Logan CV, Laissue P, Rivera C, Restrepo CM, Fonseca DJ, Morgan JE, Allanore Y, Fontenay M, Wipff J, Varret M, Gibault L, Dalantaeva N, Korbonits M, Zhou B, Yuan G, Harifi G, Cefle K, Palanduz S, Akoglu H, Zwijnenburg PJ, Lichtenbelt KD, Aubry-Rozier B, Superti-Furga A, Dallapiccola B, Accadia M, Brancati F, Sheridan EG, Taylor GR, Carr IM, Johnson CA, Markham AF, Bonthron DT. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Hum Mutat 2012; 33(8): 1175–1181

    Article  PubMed  CAS  Google Scholar 

  16. Seifert W, Kühnisch J, Tüysüz B, Specker C, Brouwers A, Horn D. Mutations in the prostaglandin transporter encoding gene SLCO2A1 cause primary hypertrophic osteoarthropathy and isolated digital clubbing. Hum Mutat 2012; 33(4): 660–664

    Article  PubMed  CAS  Google Scholar 

  17. Busch J, Frank V, Bachmann N, Otsuka A, Oji V, Metze D, Shah K, Danda S, Watzer B, Traupe H, Bolz HJ, Kabashima K, Bergmann C. Mutations in the prostaglandin transporter SLCO2A1 cause primary hypertrophic osteoarthropathy with digital clubbing. J Invest Dermatol 2012; 132(10): 2473–2476

    Article  PubMed  CAS  Google Scholar 

  18. Bergmann C, Wobser M, Morbach H, Falkenbach A, Wittenhagen D, Lassay L, Ott H, Zerres K, Girschick HJ, Hamm H. Primary hypertrophic osteoarthropathy with digital clubbing and palmoplantar hyperhidrosis caused by 15-PGHD/HPGD loss-of-function mutations. Exp Dermatol 2011; 20(6): 531–533

    Article  PubMed  CAS  Google Scholar 

  19. Sinibaldi L, Harifi G, Bottillo I, Iannicelli M, El Hassani S, Brancati F, Dallapiccola B. A novel homozygous splice site mutation in the HPGD gene causes mild primary hypertrophic osteoarthropathy. Clin Exp Rheumatol 2010; 28(2): 153–157

    PubMed  CAS  Google Scholar 

  20. Diggle CP, Carr IM, Zitt E, Wusik K, Hopkin RJ, Prada CE, Calabrese O, Rittinger O, Punaro MG, Markham AF, Bonthron DT. Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy. Rheumatology (Oxford) 2010; 49(6): 1056–1062

    Article  CAS  Google Scholar 

  21. Tariq M, Azeem Z, Ali G, Chishti MS, Ahmad W. Mutation in the HPGD gene encoding NAD+ dependent 15-hydroxyprostaglandin dehydrogenase underlies isolated congenital nail clubbing (ICNC). J Med Genet 2009; 46(1): 14–20

    Article  PubMed  CAS  Google Scholar 

  22. Sasaki T, Niizeki H, Shimizu A, Shiohama A, Hirakiyama A, Okuyama T, Seki A, Kabashima K, Otsuka A, Ishiko A, Tanese K, Miyakawa S, Sakabe J, Kuwahara M, Amagai M, Okano H, Suematsu M, Kudoh J. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotypegenotype correlation in Japanese patients with pachydermoperiostosis. J Dermatol Sci 2012; 68(1): 36–44

    Article  PubMed  CAS  Google Scholar 

  23. Ursing B. Pachydermoperiostosis. Acta Med Scand 1970; 188(3): 157–160

    PubMed  CAS  Google Scholar 

  24. Cantatore FP, Mancini L, Ingrosso AM, Carrozzo M. Pachydermoperiostosis: dermatological, neurological and radiological observations. Clin Rheumatol 1995; 14(6): 705–707

    Article  PubMed  CAS  Google Scholar 

  25. Jajic I, Jajic Z, Grazio S. Minor but important symptoms and signs in primary hypertrophic osteoarthropathy. Clin Exp Rheumatol 2001; 19(3): 357–358

    Article  PubMed  CAS  Google Scholar 

  26. Saigal R, Kansal A, Mittal M, Singh Y, Ram H. Pachydermoperiostosis with myelofibrosis and empty sella. J Assoc Physicians India 2010; 58: 253–255

    PubMed  Google Scholar 

  27. Martinez-Lavin M. Exploring the cause of the most ancient clinical sign of medicine: finger clubbing. Semin Arthritis Rheum 2007; 36 (6): 380–385

    Article  PubMed  Google Scholar 

  28. de Vernejoul MC, Kornak U. Heritable sclerosing bone disorders: presentation and new molecular mechanisms. Ann N Y Acad Sci 2010; 1192(1): 269–277

    Article  PubMed  Google Scholar 

  29. Narayanan S, Mohamed Gani VM, Sundararaju V. Primary hypertrophic osteoarthropathy with hypertrophic gastropathy. J Clin Rheumatol 2010; 16(4): 190–192

    Article  PubMed  Google Scholar 

  30. Martínez-Lavín M. Digital clubbing and hypertrophic osteoarthropathy: a unifying hypothesis. J Rheumatol 1987; 14(1): 6–8

    PubMed  Google Scholar 

  31. Dickinson CJ, Martin JF. Megakaryocytes and platelet clumps as the cause of finger clubbing. Lancet 1987; 330(8573): 1434–1435

    Article  Google Scholar 

  32. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996; 347(9002): 702

    Article  PubMed  CAS  Google Scholar 

  33. Soubrier M, Dubost JJ, Serre AF, Ristori JM, Sauvezie B, Cathebras P, Piette JC, Chapman A, Authier FJ, Gherardi RK. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 1997; 40(4): 786–787

    Article  PubMed  CAS  Google Scholar 

  34. Silveira LH, Martínez-Lavín M, Pineda C, Fonseca MC, Navarro C, Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000; 18(1): 57–62

    PubMed  CAS  Google Scholar 

  35. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25(4): 581–611

    Article  PubMed  CAS  Google Scholar 

  36. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13(1): 9–22

    PubMed  CAS  Google Scholar 

  37. Towler DA. Vascular biology and bone formation: hints from HIF. J Clin Invest 2007; 117(6): 1477–1480

    Article  PubMed  CAS  Google Scholar 

  38. Olán F, Portela M, Navarro C, Gaxiola M, Silveira LH, Ruiz V, Martínez-Lavín M. Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. Correlation with disease activity. J Rheumatol 2004; 31(3): 614–616

    PubMed  Google Scholar 

  39. Vazquez-Abad D, Martinez-Lavin M. Macrothrombocytes in the peripheral circulation of patients with cardiogenic hypertrophic osteoarthropathy. Clin Exp Rheumatol 1991; 9(1): 59–62

    PubMed  CAS  Google Scholar 

  40. Nomura T, Lu R, Pucci ML, Schuster VL. The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase. Mol Pharmacol 2004; 65(4): 973–978

    Article  PubMed  CAS  Google Scholar 

  41. Schuster VL. Prostaglandin transport. Prostaglandins Other Lipid Mediat 2002; 68-69: 633–647

    Article  PubMed  CAS  Google Scholar 

  42. Endo S, Nomura T, Chan BS, Lu R, Pucci ML, Bao Y, Schuster VL. Expression of PGT in MDCK cell monolayers: polarized apical localization and induction of active PG transport. Am J Physiol Renal Physiol 2002; 282(4): F618–F622

    PubMed  CAS  Google Scholar 

  43. Cattral MS, Altraif I, Greig PD, Blendis L, Levy GA. Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease. Am J Med 1994; 97(4): 369–373

    Article  PubMed  CAS  Google Scholar 

  44. Coggins KG, Latour A, Nguyen MS, Audoly L, Coffman TM, Koller BH. Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus. Nat Med 2002; 8(2): 91–92

    Article  PubMed  CAS  Google Scholar 

  45. Chang HY, Locker J, Lu R, Schuster VL. Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice. Circulation 2010; 121(4): 529–536

    Article  PubMed  CAS  Google Scholar 

  46. Martínez-Lavín M, Pineda C, Navarro C, Buendía A, Zabal C. Primary hypertrophic osteoarthropathy: another heritable disorder associated with patent ductus arteriosus. Pediatr Cardiol 1993; 14 (3): 181–182

    Article  PubMed  Google Scholar 

  47. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994; 93(6): 2490–2496

    Article  PubMed  CAS  Google Scholar 

  48. Fabre JE, Nguyen M, Athirakul K, Coggins K, McNeish JD, Austin S, Parise LK, FitzGerald GA, Coffman TM, Koller BH. Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. J Clin Invest 2001; 107(5): 603–610

    Article  PubMed  CAS  Google Scholar 

  49. Nguyen S, Hojjati M. Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy. Clin Rheumatol 2011; 30 (1): 7–13

    Article  PubMed  Google Scholar 

  50. Jayakar BA, Abelson AG, Yao Q. Treatment of hypertrophic osteoarthropathy with zoledronic acid: case report and review of the literature. Semin Arthritis Rheum 2011; 41(2): 291–296

    Article  PubMed  Google Scholar 

  51. Tanaka H, Maehama S, Imanaka F, Sakai A, Abe K, Hamada M, Yamashita J, Kimura A, Imamura N, Fujimura K, Kuramoto A. Pachydermoperiostosis with myelofibrosis and anemia: report of a case of anemia of multifactorial causes and its improvement with steroid pulse and iron therapy. Jpn J Med 1991; 30(1): 73–80

    Article  PubMed  CAS  Google Scholar 

  52. Ninomiya S, Hara T, Tsurumi H, Kanemura N, Kasahara S, Ogawa Y, Seishima M, Hirose Y, Moriwaki H. Myelofibrosis successfully treated with prednisolone in a patient with pachydermoperiostosis. Intern Med 2011; 50(19): 2207–2211

    Article  PubMed  CAS  Google Scholar 

  53. Monteiro E, Carvalho P, Silva A, Ferraro A. Frontal rhytidectomy: a new approach to improve deep wrinkles in a case of pachydermoperiostosis. Plast Reconstr Surg 2003; 112(4): 1189–1191

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Metabolic Bone Disease and Genetic Research Unit, Department of Osteoporosis and Bone Diseases, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, 200233, China

    Zeng Zhang & Zhenlin Zhang

  2. Department of Orthopedic Surgery, Shanghai Jiao Tong University Affliated Sixth People’s Hospital, Shanghai, 200233, China

    Zeng Zhang & Changqing Zhang

Authors
  1. Zeng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Changqing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhenlin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhenlin Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Z., Zhang, C. & Zhang, Z. Primary hypertrophic osteoarthropathy: an update. Front. Med. 7, 60–64 (2013). https://doi.org/10.1007/s11684-013-0246-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-013-0246-6

Keywords

Search

Navigation